Natalizumab treatment for multiple sclerosis

Natalizumab treatment for multiple sclerosis

Saved in:

Bibliographic Details
Main Author:	Ferreira,Maria Lucia Brito
Format:	Digital revista
Language:	English
Published:	Academia Brasileira de Neurologia - ABNEURO 2014
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014001200911
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Natalizumab and multiple sclerosis
by: Pimentel,Maria Lucia Vellutini
Published: (2013)

Natalizumab adverse events are rare in patients with multiple sclerosis
by: Fragoso,Yára Dadalti, et al.
Published: (2013)

Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients
by: Nali,Luiz Henrique da Silva, et al.
Published: (2014)

Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers
by: Oliveira,Enedina Maria Lobato de, et al.
Published: (2015)

Real-world effectiveness of natalizumab treatment in patients with relapsing multiple sclerosis in Argentina and Chile
by: Ysrraelit,Maria Celica, et al.
Published: (2021)

Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive
by: Fragoso,Yara Dadalti, et al.
Published: (2013)

Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
by: Fragoso,Yara Dadalti, et al.
Published: (2016)

Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis
by: Marques,Vanessa Daccach, et al.
Published: (2018)

Cognitive deficits in multiple sclerosis: a systematic review
by: Ferreira,Maria Lúcia Brito
Published: (2010)

Comparing neuromyelitis optica and multiple sclerosis severity: is there a difference?
by: Ferreira,Maria Lúcia Brito
Published: (2013)

Global adherence to pharmacotherapeutic treatment in patients with multiple sclerosis
by: Ballester Martínez,N, et al.
Published: (2021)

Assessment of patients with multiple sclerosis according to tests of the Multiple Sclerosis Functional Composite
by: Figueiredo,Anelise Ineu, et al.
Published: (2016)

The cost of medication and the cost of treatment are not the same thing for multiple sclerosis
by: Fragoso,Yara Dadalti
Published: (2013)

Factors associated with adherence to immunomodulator treatment in people with multiple sclerosis
by: Câmara,Nair Assunta Antônia Corso, et al.
Published: (2017)

Meningioma growth during interferon beta-1a treatment for multiple sclerosis
by: Gama,Hugo Pereira Pinto, et al.
Published: (2008)

Psychiatric manifestations in multiple sclerosis patients and multiple sclerosis in psychiatric patient
by: Fragoso,Yára Dadalti, et al.
Published: (2009)

How much radiologically isolated syndrome suggestive of multiple sclerosis is multiple sclerosis?
by: Lana-Peixoto,Marco Aurélio
Published: (2012)

Evaluation of diagnosis and treatment practices of Brazilian neurologists among patients with multiple sclerosis
by: Marin,Cássia Elisa, et al.
Published: (2021)

Immunomodulatory treatment in multiple sclerosis: experience at a Brazilian center with 390 patients
by: Tilbery,Charles Peter, et al.
Published: (2006)

Pediatric multiple sclerosis in Venezuela
by: Peña,Joaquín A., et al.
Published: (2012)

Cambio de natalizumab a fingolimod: ¿reducción del período de lavado?
by: Sánchez-Gundín,Julia, et al.
Published: (2015)

Multiple sclerosis and herpesvirus interaction
by: Olival,Guilherme Sciascia do, et al.
Published: (2013)

Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
by: Spessotto,Caroline Vieira, et al.
Published: (2016)

The internet racing ahead of the scientific evidence: the case of "liberation treatment" for multiple sclerosis
by: Fragoso,Yára Dadalti
Published: (2011)

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
by: Deffontaines-Rufin,S., et al.
Published: (2011)

Olfactory dysfunction as a marker of multiple sclerosis progression
by: Pimentel,Maria Lucia Vellutini
Published: (2016)

Nutritional profile of multiple sclerosis
by: Redondo Robles,L., et al.
Published: (2019)

Multiple sclerosis in South Africa
by: Modi,Girish, et al.
Published: (2008)

Bipolar disorder and multiple sclerosis
by: Ybarra,Mariana Inés, et al.
Published: (2007)

Prevalence of depression in multiple sclerosis
by: Andrade,A P T G
Published: (2011)

Physiopathology of symptoms and signs in multiple sclerosis
by: Sá,Maria José
Published: (2012)

Benign multiple sclerosis: aspects of cognition and neuroimaging
by: Ton,Alyne Mendonça Marques, et al.
Published: (2017)

Is multiple sclerosis in Brazil and asia alike?
by: Lana-Peixoto,Marco Aurélio, et al.
Published: (1992)

Migraine in 746 patients with multiple sclerosis
by: Fragoso,Yara Dadalti, et al.
Published: (2019)

How to choose initial treatment in multiple sclerosis patients: a case-based approach
by: Apóstolos,Samira Luisa Pereira, et al.
Published: (2022)

Telangiectasias bleeding in patient with multiple sclerosis
by: Martínez-Caselles,Alejandro, et al.
Published: (2011)

Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis
by: Rodrigues,Maria Carolina de Oliveira, et al.
Published: (2013)

Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment
by: Malhotra, Sunny, et al.
Published: (2013-10)

Modifiable environmental factors in multiple sclerosis
by: Fragoso,Yara Dadalti
Published: (2014)

Schistosomiasis protects against multiple sclerosis
by: La Flamme,Anne Camille, et al.
Published: (2004)

Resource Map